Abiopharma

🔍 DEMARTINO STEVEN A (Executive)

Company: TRANSACT TECHNOLOGIES INC (TACT)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 10,100 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 197,949.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,467 shares of Common Stock at $3.32 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 194,482.00 | transaction_form_type: 4
• Sold 10,100 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 30,300.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1

Footnotes:

• F1: Shares of Restricted Stock Units issued on May 1, 2025 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.